Global CRISPR-Based Diagnostics Market, Global CRISPR-Based Diagnostics Market Report, Global CRISPR-Based Diagnostics Market Trends, Global CRISPR-Based Diagnostics Market Size

Global CRISPR-Based Diagnostics Market 2025–2029: Competitive Insights and Opportunities

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The CRISPR-Based Diagnostics Industry In 2025?

The crispr-based diagnostics market size has seen rapid expansion in recent years. It is anticipated to expand from $4.35 billion in 2024 to $5.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.3%. The market’s past growth can be linked to increased healthcare spending, a surge in demand for gene editing, the growing prevalence and incidence of chronic diseases, heightened awareness of treatments, and an increase in the occurrence of genetic diseases.

The crispr-based diagnostics market is projected to experience swift expansion in the coming years, with its size forecast to reach $9.77 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.6%. This anticipated growth is driven by several factors, including an increasing need for quick and precise diagnostic tools, expanding uses in identifying infectious diseases, financial support from governments and institutions, enhanced methods for detecting antibiotic resistance, and greater public understanding and adoption of CRISPR technologies. Key developments expected during this period involve point-of-care (POC) testing, the utilization of CRISPR-Cas12 and Cas13 systems, advancements in personalized medicine and genetic screening, the combination with nanotechnology and biosensors, and the application of CRISPR for early disease detection.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp

Which Factors And Drivers Are Influencing The CRISPR-Based Diagnostics Market In 2025?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the CRISPR-based diagnostics market in the future. These diseases are conditions resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of transmission between individuals directly or indirectly, via tainted surfaces, food, water, or vectors such as insects. The frequency of infectious diseases is increasing due to influences including globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and inadequate healthcare availability. CRISPR-based diagnostics improve efforts to combat infectious diseases by offering swift and precise pathogen detection, thereby enabling early diagnosis, prompt intervention, and efficient containment strategies. For example, data released by the UK Health Security Agency, a UK-based executive agency, indicated that in England, in August 2024, the UK Health Security Agency (UKHSA) documented 368 measles cases in 2023. This represented a nearly sevenfold increase compared to the 53 cases reported in 2022, with the West Midlands and London contributing 44% and 33% of these cases, respectively. Consequently, the escalating occurrence of infectious diseases is propelling the CRISPR-based diagnostics market.

What Are The Different Segment Classifications Within The CRISPR-Based Diagnostics Market?

The crispr-based diagnosticsmarket covered in this report is segmented –

1) By Product: Kits; Buffer Solutions; Software; Other Products

2) By Technique: Recombinase Polymerase Amplification (RPA); Loop-mediated Isothermal Amplification (LAMP); Other Techniques

3) By Disease: Infectious Diseases; Non-Infectious Diseases

4) By End-User: Hospitals; Diagnostic Centers; Biotechnology Companies; Academic And Research Institutes; Other End-Users

Subsegments:

1) By Kits: CRISPR Detection Kits; CRISPR Amplification Kits; CRISPR-Based Assay Kits

2) By Buffer Solutions: CRISPR Reaction Buffers; CRISPR Lysis Buffers

3) By Software: CRISPR Data Analysis Software; CRISPR Design Software; CRISPR Diagnostic Platforms Software

4) By Other Products: CRISPR Enzymes; CRISPR Reagents; CRISPR-Based Probes

Which Trends Are Impacting The CRISPR-Based Diagnostics Market?

Leading companies within the CRISPR-based diagnostics market are prioritizing the formation of strategic partnerships to improve the availability of rapid and accurate diagnostics through CRISPR-based point-of-care tests. A strategic partnership denotes a long-term cooperative agreement between two or more organizations that pool resources and expertise to achieve shared objectives and bolster their competitive advantage. For instance, in August 2023, CrisprBits Private Limited, an India-based biotechnology company, announced a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics company, for the development of CRISPR-based Point-of-Care Tests (POCTs). This joint effort focuses on devising quick, precise, and cost-effective diagnostic tools that leverage CRISPR technology to detect pathogens and genetic markers. These POCTs are designed to enhance diagnostic accessibility across various settings, including resource-limited regions, while ensuring prompt and accurate disease detection. The partnership merges CrisprBits’ specialized knowledge in CRISPR-based platforms with Molbio’s manufacturing and distribution strengths to introduce these tests to a worldwide market.

Which Leading Companies Dominate The CRISPR-Based Diagnostics Market Share?

Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

What Are The Regional Market Dynamics Impacting The CRISPR-Based Diagnostics Industry?

North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The CRISPR-Based Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20734&type=smp

Browse Through More Reports Similar to the Global CRISPR-Based Diagnostics Market 2025, By The Business Research Company

Medical And Diagnostic Laboratory Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Anesthesia And Respiratory Devices Market 2025

https://www.thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795